Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 50.91

-2.5%

2:51 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry Liebman who wrote (490)	1/6/2000 1:53:00 PM
From: Biomaven	Read Replies (1) of 52153

Larry, And PCOP responded very nicely indeed (currently +20%). This was a stock I held unsuccessfully in 1998 and gave up on then, missing its nice recent comeback. It's hard to keep an open mind and go back to a stock that's disappointed you. Aside from the genomics frenzy which has distorted things some (not that I'm complaining, mind you), we are definitely seeing a willingness by analysts to look beyond AMGN. In particular, I've noticed some nice support for some smaller biotechs from Robbie Stephens. We've also seen our first "over the top" price target (INCY from Alex Brown). Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next